Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_assertion type Assertion NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_head.
- NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_assertion description "[Analysis of 209 neuroblastoma patient tumors revealed that, in contrast with ABCC1 and ABCC4, low rather than high ABCC3 expression was associated with reduced event-free survival (HR of recurrence or death = 2.4, 95% CI = 1.4 to 4.2; P = .001), with 23 of 53 patients with low ABCC3 expression experiencing recurrence or death compared with 31 of 155 patients with high ABCC3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_provenance.
- NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_assertion evidence source_evidence_literature NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_provenance.
- NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_assertion SIO_000772 21799180 NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_provenance.
- NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_assertion wasDerivedFrom befree-20150227 NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_provenance.
- NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_assertion wasGeneratedBy ECO_0000203 NP802477.RA3lN9a9HKvYxxfVi24SATrLV63SZT0u3N9WiRvmbSrIM130_provenance.